Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
CAL-101 by Calluna Pharma for Inflammation: Likelihood of Approval
CAL-101 is under clinical development by Calluna Pharma and currently in Phase I for Inflammation. According to GlobalData, Phase I...
CAL-101 by Calluna Pharma for Fibrosis: Likelihood of Approval
CAL-101 is under clinical development by Calluna Pharma and currently in Phase I for Fibrosis. According to GlobalData, Phase I...
CAL-101 by Calluna Pharma for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval
CAL-101 is under clinical development by Calluna Pharma and currently in Phase I for Plaque Psoriasis (Psoriasis Vulgaris). According to...